Indeed, metformin suppressed the stimulatory effects of obesity and hyperinsulinemia on lung tumor growth in mice by improving insulin sensitivity, lowering circulating insulin, and activating AMPK signaling [13]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.